1. The target landscape of clinical kinase drugs
   Susan Klaeger et al, 2017, Science CrossRef
2. Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research
   Zhixiang Wang, 2016, IJMS CrossRef
3. Synergistic anti-proliferative effects of mTOR and MEK inhibitors in high-grade chondrosarcoma cell line OUMS-27
   Singo Fukumoto et al, 2018, Acta Histochemica CrossRef
4. Src nuclear localization and its prognostic relevance in human osteosarcoma
   Enrica Urciuoli et al, 2018, J Cell Physiol CrossRef
5. Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification.
   Bob Meeusen et al, 2018, Int J Biochem Cell Biol CrossRef
6. Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression
   Chun-Hao Tsai et al, 2017, Mol Oncol CrossRef
7. Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
   Anke E. M. van Erp et al, 2017, Targ Oncol CrossRef
8. TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway
   Muhui Lin et al, 2018, Cancer Biology & Therapy CrossRef
9. RIG-I inhibits pancreatic β cell proliferation through competitive binding of activated Src
   Yi Pan et al, 2016, Sci Rep CrossRef
10. Deciphering signaling networks in osteosarcoma pathobiology
    Christos Adamopoulos et al, 2016, Exp Biol Med (Maywood) CrossRef
11. Recent Advances in Mechanobiology of Osteosarcoma.
    Christos Adamopoulos et al, 0 CrossRef
12. Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis
    Kallirroi Voudouri et al, 2016 CrossRef
13. Design, synthesis and evaluation of azaacridine derivatives as dual-target EGFR and Src kinase inhibitors for antitumor treatment
    Zhishan Cui et al, 2017, European Journal of Medicinal Chemistry CrossRef
14. Differentially activated Src kinase in chemo-naïve human primary osteosarcoma cells and effects of a Src kinase inhibitor
    Marcella Laschi et al, 2017, BioFactors CrossRef
15. Managing sarcoma: where have we come from and where are we going?
    Jenna S. Bleloch et al, 2017, Ther Adv Med Oncol CrossRef
16. A novel Lyn-like protein tyrosine kinase identified in lamprey and its role in immune response
    Tingting Zhao et al, 2020 CrossRef
17. Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung
    Kristin Baird et al, 2020, Sarcoma CrossRef
18. Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature
    Rong-quan He et al, 2017, Oncotarget CrossRef
19. Macrophage migration inhibitory factor promotes cardiac fibroblast proliferation through the Src kinase signaling pathway
    Yu‑Mei Xue et al, 2017, Mol Med Report CrossRef
20. SPOCD1 promotes cell proliferation and inhibits cell apoptosis in human osteosarcoma
    Jinqian Liang et al, 2017, Mol Med Report CrossRef
21. null
    Courtney Schott et al, 2020 CrossRef
22. Comprehensive Analysis of Novel lncRNA-TF Regulatory Cross Talks and Identification of Core lncRNA-TF Feedback Loops in Sarcoma
    Ke Wang et al, 2020, DNA and Cell Biology CrossRef
23. Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?
    Zhichao Tian et al, 2020, Front. Oncol. CrossRef
24. Dissecting Transcription Factor-Target Interaction in Bovine Coronavirus Infection
    Olanrewaju B. Morenikeji et al, 2020, Microorganisms CrossRef
25. Design and screening of SGK1, Src dual inhibitors using pharmacophore models, molecular docking, and molecular dynamics simulation
    Chuan-ce Sun et al, 2020, New J. Chem. CrossRef
26. Future Directions in the Treatment of Osteosarcoma.
    Alannah Smrke et al, 2021, Cells CrossRef
27. Recent advances in pharmacological diversification of Src family kinase inhibitors
    Preeya Negi et al, 2021, Egypt J Med Hum Genet CrossRef
28. Dual target inhibitors based on EGFR: Promising anticancer agents for the treatment of cancers (2017-)
    Liping Hu et al, 2021, European Journal of Medicinal Chemistry CrossRef
29. Nanodesigning of multifunctional quantum dots and nanoparticles for the treatment of fibrosarcoma
    Gulen Melike Demirbolat et al, 2021, Journal of Microencapsulation CrossRef
30. The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.
    Garima Singh et al, 2016, J Biol Chem CrossRef
31. Targeting the FAK-Src Complex in Desmoplastic Small Round Cell Tumors, Ewing Sarcoma, and Rhabdomyosarcoma
    Anke E. M. van Erp et al, 2022, Sarcoma CrossRef
32. Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing
    Rawikant Kamolphiwong et al, 2022, Gene CrossRef
33. Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship
    A. Katharina Ceranski et al, 2023, Mol Cancer CrossRef
34. Morin inhibits osteosarcoma migration and invasion by suppressing urokinase plasminogen activator through a signal transducer and an activator of transcription 3
    Jia‐Sin Yang et al, 2023, Environmental Toxicology CrossRef